Tokyo, Japan

Takanori Hama

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Cellseed, Inc., The Jikei University, Tokyo Women's Medical University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takanori Hama. Retrieved from https://idiyas.com/inventor/takanori-hama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takanori Hama: Innovator in Middle Ear Cell Technology

Introduction

Takanori Hama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in the development of cell sheets for middle ear applications. His innovative work aims to improve treatments for conditions affecting the middle ear.

Latest Patents

Hama holds a patent for a "Middle ear mucosa-like cell sheet, process of producing the same and method of using the same." The purpose of this invention is to provide an alternative to mucosal substitutes in the middle ear. This invention helps suppress hyperplasia of granulation tissue and bone, as well as the development of fibroblast cells in the middle ear. The process involves culturing nasal epithelium cells on a specially coated substrate, allowing for the recovery of a cell sheet that retains cilia in its surface layer.

Career Highlights

Throughout his career, Takanori Hama has worked with prestigious institutions, including Tokyo Women's Medical University and The Jikei University. His research has focused on innovative solutions to medical challenges, particularly in otolaryngology.

Collaborations

Hama has collaborated with notable colleagues such as Hiromi Kojima and Hiroshi Moriyama. Their combined expertise has contributed to advancements in the field of medical technology.

Conclusion

Takanori Hama's work in developing middle ear mucosa-like cell sheets represents a significant advancement in medical technology. His innovative approach has the potential to improve treatment outcomes for patients with middle ear conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…